BioRestorative Therapies (BRTX) announced that the FDA has granted Fast Track designation to the BRTX-100 program for the treatment chronic lumbar disc disease.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BRTX: